Interaction databaseSupplement × PrescriptionReviewed May 2026

Methylfolate and Trimethoprim-Sulfamethoxazole, a caution.

Trimethoprim inhibits dihydrofolate reductase and can cause folate deficiency with prolonged use, particularly in people with marginal folate status, pregnancy, or chronic illness. Methylfolate supplementation can correct this deficiency without interfering with the antibiotic's antibacterial activity, since trimethoprim is highly selective for bacterial dihydrofolate reductase. However, very high folate intake near antibiotic dosing has theoretical potential to reduce antibacterial efficacy in some infections.

One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.

Sourcing standards·Evidence tiers

From the interaction database

What the row says.

Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.

At a glance

Substances
Methylfolate and Trimethoprim-Sulfamethoxazole
Pair type
Caution
Evidence (highest tier)
Moderate
Source citations
2 sources
Stack Score effect
−5 to your Stack Score (per scored caution row).
Scope
Supplement × Prescription
Last verified
May 30, 2026

Caution · Moderate evidence

Caution

What is happening. Trimethoprim inhibits dihydrofolate reductase and can cause folate deficiency with prolonged use, particularly in people with marginal folate status, pregnancy, or chronic illness. Methylfolate supplementation can correct this deficiency without interfering with the antibiotic's antibacterial activity, since trimethoprim is highly selective for bacterial dihydrofolate reductase. However, very high folate intake near antibiotic dosing has theoretical potential to reduce antibacterial efficacy in some infections.

Mechanism. Trimethoprim selectively inhibits bacterial dihydrofolate reductase but can also weakly affect host folate metabolism in long courses. Methylfolate bypasses the dihydrofolate reductase step entirely by providing the active 5-methyltetrahydrofolate form.

Recommendation. Methylfolate supplementation is generally safe during trimethoprim-sulfamethoxazole therapy and is recommended for prolonged courses, pregnancy, or pre-existing folate deficiency. Separate doses by at least 2 hours to be conservative.

Minimum separation. 120

Sources (2)
  1. Lipsky JJ. Antibacterial agents and folate metabolism. Postgrad Med J. 1990;66 Suppl 5:S39-44. PMID 2717509
  2. Smit MJ, de Groot R, van Dongen JJ, et al. Pneumocystis carinii pneumonia in patients with a severe combined immunodeficiency. Ned Tijdschr Geneeskd. 1991;135(1):24-6. PMID 1990300

Stack Score

How this pair moves the number.

Effect on the composite score

If both Methylfolate and Trimethoprim-Sulfamethoxazole are in the same stack, this pair applies −5 to your Stack Score (per scored caution row).

The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.

Check your full routine

One pair was the worked example. NutriStack runs every pair in your stack at once.

Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.